![[Main Media] [Funds Focus] Bridge](https://carmignac.imgix.net/uploads/NextImage/0001/02/26ad7f7eb70cc9f1137127c5b230d8042189f9e1.jpeg?auto=format%2Ccompress&crop=faces&fit=crop&w=3840)
Carmignac Absolute Return Europe: Letter from the Fund Managers
Over the first quarter of 2025, Carmignac Absolute Return Europe (A EUR Acc share class) realized a negative performance of -1.99%.
Market environment
The beginning of 2025 has been a turbulent period for investors, as markets continuously recalibrated in response to geopolitical and macroeconomic events.
January commenced on a positive note, with significant inflows into European equities from global investors aiming to diversify away from the correctional markets in the US. A pivotal moment came with the German government's unexpected announcement of a €500 billion program to enhance defence and infrastructure. This initiative was widely regarded as a catalyst for European growth, anticipated to further bolster substantial inflows into European equities, especially in defence stocks and cyclical/infrastructure sectors. Consequently, European equities outperformed US equities during the quarter for the first time in many years with the Stoxx 600 outperforming the S&P500 by 10%.
US equities had experienced an exuberant rally following the election of President Trump, but soon faced potential headwinds and distortions due to the "America First" policies. Despite Trump being in office for only a few weeks, the growing uncertainty around the US government's policy agenda and its impact on economic data, coupled with frequent aggressive headlines from the administration, began to weigh on market sentiment, driving US markets into correctional territory. Concurrently, increasing skepticism about artificial intelligence (AI) and especially Data Centre expansion, prompted more cautious commentary from the industry, applying pressure on US tech stocks, including the “Magnificent 7”. This triggered a substantial de-grossing event among hedge funds. Quality stocks were generally sold off while shorts were aggressively covered, causing substantial pain for most investors and exacerbating the de-grossing. Additionally, the rapid spike in volatility severely impacted investors, impairing their ability to hedge portfolios, and thus further accelerating the market correction.
During the first two months of the quarter, European equities surged and managed to retain most of their gains, in contrast to US equities which entered negative territory. The top-performing sectors in Europe included Banks, driven by positive earnings revisions and accelerated buybacks and dividends, as well as Insurance, Telecoms, Utilities, and Construction. However, sectors such as Travel and Leisure, Media, Retail, and Autos lagged behind.
Performance review
After a strong start to the year, the portfolio encountered significant challenges in February and March due to intense market rotational forces and unprecedented levels of de-grossing, which triggered heavy selling pressure. While the main positive contributors were Financials, particularly banks, and our industrial shorts, these gains were more than offset by losses in Technology (AI sell-off), Consumer Discretionary, and Healthcare.
In such unfavourable and unpredictable market conditions, we strived to remain as disciplined as possible within the fund's restrictions and rules to manage risk. Accordingly, we reduced long exposure in Industrials, Healthcare, Consumer Discretionary, Technology, and Materials—sectors potentially vulnerable to tariffs. Additionally, we added short positions in some cyclical European names which, in our view, had rallied excessively following the German stimulus program announcement. We also initiated short positions in European names likely to be impacted by a deteriorating US consumer environment and economy.
We reduced our gross exposure from a high of 130% in January to around 100%, and our net exposure from the mid-20s to 10-15% by the end of March, fluctuating daily based on our various option hedges. Despite our best efforts to protect the portfolio, it was frustrating to watch our January profits turn into a 2% loss by the end of the quarter due to the macroeconomic and geopolitical-induced sell-offs and rotations. The last few weeks of March were among the most challenging since the onset of Covid-19, characterized by unpredictable headlines and numerous policy reversals, primarily from the US administration. Unfortunately, these challenges have persisted into early April and have worsened since Trump's 'Liberation Day.'
| Long Euronext – upgrades from elevated market trading volumes | Long Amazon – concerns about slowing economic growth |
| Long Deutsche Telekom – earnings beat from their US mobile business | Long Infineon – ongoing effects of Industrial inventory correction |
| Long Fresenius – positive earnings drive rerating | Long TSMC – profit taking in the AI theme |
| Long Piraeus Financial – positive earnings report | Long Zealand – partnership with Roche didn’t convince investors |
| Long Intesa Sanpaolo – strong net interest and fee income | Long UCB – suffered from de grossing and perceived risk from upcoming tariffs |
What is our outlook for the coming months?
Currently, the world is experiencing a period of unprecedented uncertainty. The tariff-based policy decisions introduced by the new US administration have embedded an element of 'Trump mania' into the global capital markets psyche, creating significant headline risk with dramatic consequences on a daily basis. There is a palpable risk of an all-out trade war, forcing business leaders, corporates, and investors to operate in a landscape with zero visibility, and we have yet to witness the economic ramifications in hard data and corporate earnings.
The Q1 reporting season is expected to be dominated by a loss of confidence in the earnings outlook for 2025. It would be almost surprising if management teams do not issue warnings about future prospects or significantly downplay their expectations. In these circumstances, our primary focus must be on capital preservation until this geopolitical turmoil subsides, while simultaneously retaining the ability to be reactive and opportunistic with the opportunities that will undoubtedly arise in the coming months.
Despite the greater level of uncertainty compared to previous crises, we know that they eventually come to an end. When they do, there will be incredible opportunities. For example, many of our fundamental positions, especially long ones, are now vastly oversold—even in a recession scenario, particularly within the healthcare sector—as they have suffered greatly from the widespread de-grossing. These positions should offer enormous upside potential once the geopolitical landscape stabilizes.

Carmignac Absolute Return Europe
Carmignac Absolute Return Europe A EUR Acc
- Aanbevolen minimale beleggingstermijn*
- 3 jaar
- Risicoschaal**
- 2/7
- SFDR-fondscategorieën***
- Artikel 8
*Aanbevolen minimale beleggingstermijn: Dit deelnemingsrecht/deze klasse is mogelijk niet geschikt voor beleggers die voornemens zijn hun inleg voor afloop van de aanbevolen termijn op te nemen. Deze verwijzing naar een beleggersprofiel is geen beleggingsadvies. Welk bedrag redelijkerwijs in een ICBE kan worden belegd hangt af van uw persoonlijke situatie en moet worden bekeken in relatie tot uw totale portefeuille. **Het profiel kan variëren van 1 tot 7, waarbij categorie 1 overeenkomt met een lager risico en een lager potentieel rendement, en categorie 7 met een hoger risico en een hoger potentieel rendement. De categorieën 4, 5, 6 en 7 impliceren een hoge tot zeer hoge volatiliteit, met grote tot zeer grote prijsschommelingen die op korte termijn tot latente verliezen kunnen leiden. ***De Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. De SFDR-classificatie van de fondsen kan in de loop van de tijd veranderen.
Voornaamste risico's van het Fonds
Kosten
- Instapkosten
- 4,00 % van het bedrag dat u betaalt wanneer u in deze belegging instapt. Dit is het hoogste bedrag dat u in rekening zal worden gebracht. Carmignac Gestion brengt geen instapkosten in rekening. De persoon die verantwoordelijk is voor de verkoop van het product zal u informeren over de feitelijke kosten.
- Uitstapkosten
- Wij brengen voor dit product geen uitstapkosten in rekening.
- Beheerskosten en andere administratie - of exploitatiekos ten
- 2,15 % van de waarde van uw belegging per jaar. Dit is een schatting op basis van de feitelijke kosten over het afgelopen jaar.
- Prestatievergoedingen
- 20,00 % max. van de meerprestatie als het rendement positief is en de netto-inventariswaarde de high-water mark overschrijdt. Het feitelijke bedrag zal variëren naargelang van de prestaties van uw belegging. De schatting van de totale kosten hierboven omvat het gemiddelde over de afgelopen vijf jaar, of sinds de introductie van het product als dat minder dan vijf jaar geleden is.
- Transactiekosten
- 1,05 % van de waarde van uw belegging per jaar. Dit is een schatting van de kosten die ontstaan wanneer we de onderliggende beleggingen voor het product kopen en verkopen. Het feitelijke bedrag zal variëren naargelang hoeveel we kopen en verkopen.
- Roerende voorheffing
- Belasting van dividend en rente op jaarbasis (via de simulator)
- Roerende voorheffing bij verkoop
- ─
- Taks op beursverrichtingen (TOB)
- ─
- Conversiekosten
- 0%
Rendement
| Carmignac Absolute Return Europe | −2,0 | +3,6 | +0,0 | −6,4 | +12,6 | +5,2 | −1,3 | +4,4 | +14,6 | +8,9 |
| Carmignac Absolute Return Europe | −0,9 % | +2,8 % | +2,6 % |
Bron: Carmignac op 31 mrt. 2025.
Het beheer van dit deelnemingsrecht/deze klasse is niet gebaseerd op de indicator. In het verleden behaalde resultaten en waarden bieden geen garantie voor toekomstige resultaten en waarden. De vermelde rendementen zijn netto na aftrek van alle kosten, met uitzondering van eventuele in- en uitstapkosten, en worden verkregen na aftrek van kosten en belastingen die van toepassing zijn op een gemiddelde detailhandelsklant die als natuurlijke persoon woonachtig is in België. Wanneer de valuta afwijkt van uw eigen valuta, bestaat er een valutarisico dat kan resulteren in een waardedaling. De referentievaluta van het fonds/subfonds is de EUR. Het fonds houdt een risico op kapitaalverlies in.
Het rendement kan stijgen of dalen als gevolg van valutaschommelingen voor de aandelen die niet valutadekkend zijn.
Referentie-indicator: -